|
| Sylvan C Baca | Dana-Farber Cancer Institute, Harvard Medical School |
| Sylvan C Baca | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute |
| Michael Sigouros | Englander Institute for Precision Medicine |
| Eva Corey | University of Washington |
| Mary-Ellen Taplin | Dana-Farber Cancer Institute, Harvard Medical School |
| Toni K Choueiri | Dana-Farber Cancer Institute, Harvard Medical School |
| Mark M Pomerantz | Dana-Farber Cancer Institute, Harvard Medical School |
| Mark M Pomerantz | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute |
| Mark M Pomerantz | Dana-Farber Cancer Institute, Harvard Medical School |
| Mark M Pomerantz | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute |
| Himisha Beltran | Dana-Farber Cancer Institute, Harvard Medical School |
| Himisha Beltran | Dana-Farber Cancer Institute, Harvard Medical School |
| Matthew L Freedman | Dana-Farber Cancer Institute, Harvard Medical School |
| Matthew L Freedman | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute |
| Matthew L Freedman | Dana-Farber Cancer Institute, Harvard Medical School |
| Matthew L Freedman | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute |